Kanagawa, Japan

Masato Yoshida

This inventor holds 26 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Takeda Pharmaceutical Company Limited, Matsushita Electric Industrial Co., Ltd., Canon Kabushiki Kaisha. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masato Yoshida. Retrieved from https://idiyas.com/inventor/masato-yoshida-1w9c54op

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26 

% Patents Active = 50.0

 

 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 93(Granted Patents)


Location History:

  • Takatsuki, JP (2002 - 2006)
  • Sanda, JP (2009)
  • Osaka, JP (2001 - 2013)
  • Hyogo, JP (2016)
  • Kanagawa, JP (2007 - 2023)

Company Filing History:


Years Active: 2001-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Calcium Receptor Modulating Agents
Iminopyridine Derivatives
Liquid Ejection Apparatus
High-Pressure Discharge Lamp
Molded Part
Charging Apparatus
Buck-Boost Converter
Multi-Output Power Supply
Metal Halide Lamp
Medicaments
Conveyance Method
26 patents (USPTO):Explore Patents

Title: **Masato Yoshida: Innovator in Liquid Ejection Technology and Cardiovascular Medicaments**

Introduction

Masato Yoshida, an accomplished inventor located in Kanagawa, Japan, holds a remarkable portfolio of 25 patents. His work spans significant advancements in both printing technology and pharmaceutical interventions, demonstrating his versatility and impact in diverse fields.

Latest Patents

Among his latest patents, Yoshida has developed a cutting-edge liquid ejection apparatus designed to enhance the efficiency of ink delivery systems. This apparatus comprises an ink cartridge featuring a first ink storage section and an ink tank with a second ink storage section connected to the cartridge. The innovative design includes a detection unit with a light emitting section and a light receiving section arranged strategically to ensure optimal communication between the storage sections.

In the medical realm, Yoshida has also contributed to a medicament intended for treating heart failure. This invention encompasses a compound that shows potential in preventing or treating heart failure effectively. The compound's specific formulations include unique chemical structures that are promising candidates for further development in cardiovascular therapy.

Career Highlights

Yoshida's professional journey includes pivotal roles in notable companies such as Takeda Pharmaceutical Company Limited and Matsushita Electric Industrial Co., Ltd. His experiences in these organizations have undoubtedly shaped his innovative approach and deepened his understanding of complex technological and pharmaceutical challenges.

Collaborations

Throughout his career, Yoshida has worked alongside talented colleagues, including Yuriko Kaneko and Hideaki Kiryu. These collaborations have likely fostered an environment of creativity, enabling the development of groundbreaking inventions that address critical industry needs.

Conclusion

Masato Yoshida's contributions to the fields of liquid ejection technology and heart failure treatments underscore his status as a leading inventor. His patents reflect a commitment to innovation that continues to impact industries, promising advancements that could improve lives globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…